213 related articles for article (PubMed ID: 18485383)
21. Assessment of the enhancement in predictive accuracy provided by systematic biopsy in predicting outcome for clinically localized prostate cancer.
Graefen M; Ohori M; Karakiewicz PI; Cagiannos I; Hammerer PG; Haese A; Erbersdobler A; Henke RP; Huland H; Wheeler TM; Slawin K; Scardino PT; Kattan MW
J Urol; 2004 Jan; 171(1):200-3. PubMed ID: 14665876
[TBL] [Abstract][Full Text] [Related]
22. Significant upgrading affects a third of men diagnosed with prostate cancer: predictive nomogram and internal validation.
Chun FK; Briganti A; Shariat SF; Graefen M; Montorsi F; Erbersdobler A; Steuber T; Salonia A; Currlin E; Scattoni V; Friedrich MG; Schlomm T; Haese A; Michl U; Colombo R; Heinzer H; Valiquette L; Rigatti P; Roehrborn CG; Huland H; Karakiewicz PI
BJU Int; 2006 Aug; 98(2):329-34. PubMed ID: 16879673
[TBL] [Abstract][Full Text] [Related]
23. A direct comparison of the diagnostic accuracy of three prostate cancer nomograms designed to predict the likelihood of a positive initial transrectal biopsy.
Ouzaid I; Yates DR; Hupertan V; Mozer P; Chartier-Kastler E; Haertig A; Bitker MO; Rouprêt M
Prostate; 2012 Aug; 72(11):1200-6. PubMed ID: 22213470
[TBL] [Abstract][Full Text] [Related]
24. Multifocal high grade prostatic intraepithelial neoplasia is a risk factor for subsequent prostate cancer.
Lee MC; Moussa AS; Yu C; Kattan MW; Magi-Galluzzi C; Jones JS
J Urol; 2010 Nov; 184(5):1958-62. PubMed ID: 20846692
[TBL] [Abstract][Full Text] [Related]
25. Prostate cancer detection in men with prior high grade prostatic intraepithelial neoplasia or atypical prostate biopsy.
Park S; Shinohara K; Grossfeld GD; Carroll PR
J Urol; 2001 May; 165(5):1409-14. PubMed ID: 11342887
[TBL] [Abstract][Full Text] [Related]
26. Predicting the presence and side of extracapsular extension: a nomogram for staging prostate cancer.
Ohori M; Kattan MW; Koh H; Maru N; Slawin KM; Shariat S; Muramoto M; Reuter VE; Wheeler TM; Scardino PT
J Urol; 2004 May; 171(5):1844-9; discussion 1849. PubMed ID: 15076291
[TBL] [Abstract][Full Text] [Related]
27. Prognostic significance of high grade prostatic intraepithelial neoplasia and atypical small acinar proliferation in the contemporary era.
Moore CK; Karikehalli S; Nazeer T; Fisher HA; Kaufman RP; Mian BM
J Urol; 2005 Jan; 173(1):70-2. PubMed ID: 15592031
[TBL] [Abstract][Full Text] [Related]
28. Assessing individual risk for prostate cancer.
Nam RK; Toi A; Klotz LH; Trachtenberg J; Jewett MA; Appu S; Loblaw DA; Sugar L; Narod SA; Kattan MW
J Clin Oncol; 2007 Aug; 25(24):3582-8. PubMed ID: 17704405
[TBL] [Abstract][Full Text] [Related]
29. Use of prostate-specific antigen velocity to follow up patients with isolated high-grade prostatic intraepithelial neoplasia on prostate biopsy.
Loeb S; Roehl KA; Yu X; Han M; Catalona WJ
Urology; 2007 Jan; 69(1):108-12. PubMed ID: 17270629
[TBL] [Abstract][Full Text] [Related]
30. Development of improved nomogram for prediction of outcome of initial prostate biopsy using readily available clinical information.
Zaytoun OM; Kattan MW; Moussa AS; Li J; Yu C; Jones JS
Urology; 2011 Aug; 78(2):392-8. PubMed ID: 21705045
[TBL] [Abstract][Full Text] [Related]
31. PCA3 molecular urine test for predicting repeat prostate biopsy outcome in populations at risk: validation in the placebo arm of the dutasteride REDUCE trial.
Aubin SM; Reid J; Sarno MJ; Blase A; Aussie J; Rittenhouse H; Rittmaster R; Andriole GL; Groskopf J
J Urol; 2010 Nov; 184(5):1947-52. PubMed ID: 20850153
[TBL] [Abstract][Full Text] [Related]
32. Prediction of indolent prostate cancer: validation and updating of a prognostic nomogram.
Steyerberg EW; Roobol MJ; Kattan MW; van der Kwast TH; de Koning HJ; Schröder FH
J Urol; 2007 Jan; 177(1):107-12; discussion 112. PubMed ID: 17162015
[TBL] [Abstract][Full Text] [Related]
33. Models to predict positive prostate biopsies using the Tyrol screening study.
Sooriakumaran P; John M; Christos P; Bektic J; Bartsch G; Leung R; Herman M; Scherr D; Tewari A
Urology; 2011 Oct; 78(4):924-9. PubMed ID: 21840579
[TBL] [Abstract][Full Text] [Related]
34. Initial biopsy outcome prediction--head-to-head comparison of a logistic regression-based nomogram versus artificial neural network.
Chun FK; Graefen M; Briganti A; Gallina A; Hopp J; Kattan MW; Huland H; Karakiewicz PI
Eur Urol; 2007 May; 51(5):1236-40; discussion 1241-3. PubMed ID: 16945477
[TBL] [Abstract][Full Text] [Related]
35. Prognostic significance of alpha-methylacyl-coA racemase among men with high grade prostatic intraepithelial neoplasia in prostate biopsies.
Stewart J; Fleshner N; Cole H; Toi A; Sweet J
J Urol; 2008 May; 179(5):1751-5; discussion 1755. PubMed ID: 18343427
[TBL] [Abstract][Full Text] [Related]
36. The impact of obesity on the diagnosis of prostate cancer using a modern extended biopsy scheme.
Pruthi RS; Swords K; Schultz H; Carson CC; Wallen EM
J Urol; 2009 Feb; 181(2):574-7; discussion 578. PubMed ID: 19084847
[TBL] [Abstract][Full Text] [Related]
37. Validation of Partin tables and development of a preoperative nomogram for Japanese patients with clinically localized prostate cancer using 2005 International Society of Urological Pathology consensus on Gleason grading: data from the Clinicopathological Research Group for Localized Prostate Cancer.
Naito S; Kuroiwa K; Kinukawa N; Goto K; Koga H; Ogawa O; Murai M; Shiraishi T;
J Urol; 2008 Sep; 180(3):904-9; discussion 909-10. PubMed ID: 18635221
[TBL] [Abstract][Full Text] [Related]
38. Predictors of prostate cancer after initial negative systematic 12 core biopsy.
Singh H; Canto EI; Shariat SF; Kadmon D; Miles BJ; Wheeler TM; Slawin KM
J Urol; 2004 May; 171(5):1850-4. PubMed ID: 15076292
[TBL] [Abstract][Full Text] [Related]
39. Utility of percent free prostate-specific antigen in repeat prostate biopsy.
Lee BH; Hernandez AV; Zaytoun O; Berglund RK; Gong MC; Jones JS
Urology; 2011 Aug; 78(2):386-91. PubMed ID: 21683989
[TBL] [Abstract][Full Text] [Related]
40. Clinical utility of the PCA3 urine assay in European men scheduled for repeat biopsy.
Haese A; de la Taille A; van Poppel H; Marberger M; Stenzl A; Mulders PF; Huland H; Abbou CC; Remzi M; Tinzl M; Feyerabend S; Stillebroer AB; van Gils MP; Schalken JA
Eur Urol; 2008 Nov; 54(5):1081-8. PubMed ID: 18602209
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
